Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Jackson, AU
Adrian Jackson, Ferny Creek AU
| Patent application number | Description | Published |
|---|---|---|
| 20100173161 | Welding of Functional Components to Polymer Composite Components - A method for joining functional components with at least a thermoplastic components to thermosetting composites with at least some thermoplastic surface. The thermosetting composite has a functional thermoplastic surface layer attached by a process of selection of a compatible thermoplastic, heating the combined materials to allow migration of uncured thermosetting polymer into the thermoplastic polymer, then cooling the combined materials to provide a strongly attached thermoplastic surface. The thermosetting composite component may have a polymeric material coating. The present invention subsequently relates to the joining of the functional component and thermosetting polymer composite components, using high-speed oscillating relative displacement or high-speed continuous relative displacement. | 07-08-2010 |
Brad Jackson, Coorparoo AU
| Patent application number | Description | Published |
|---|---|---|
| 20110093441 | Method for Detecting a Delinquent Customer Record in a CRM Database - The present invention relates to a method for detecting a delinquent or dormant customer record in a customer relationship management (CRM) database using a computer arrangement. The method includes the step of determining that the customer record does not relate to an existing customer for whom work is in progress. It is also determined that the customer record does not relate to a prospective customer. The method further includes the step of detecting the customer record when a future activity date associated with the customer record has passed. | 04-21-2011 |
Brent Jackson, New South Wales AU
| Patent application number | Description | Published |
|---|---|---|
| 20110314413 | USER INTERFACE - A graphical user interface ( | 12-22-2011 |
Christopher John Jackson, Mt. Colah AU
| Patent application number | Description | Published |
|---|---|---|
| 20080293631 | Treatment for Autoimmune and Inflammatory Conditions - The present invention provides methods for preventing the elevation of blood glucose levels, for preventing or delaying the onset of autoimmune and inflammatory diseases or glucose-associated conditions, and for preventing or reducing inflammation in individuals suffering from an autoimmune or inflammatory diseases, the methods comprising administering to subjects in need thereof an effective amount of activated Protein C or precursor Protein C. | 11-27-2008 |
David C. Jackson, North Balwyn AU
| Patent application number | Description | Published |
|---|---|---|
| 20080233143 | Adjuvanting Material - The present invention provides an adjuvanting material, the adjuvanting material comprising a lipid dendritic cell targeting moiety to which is covalently linked a metal chelating group. Further, the present invention provides an immunogenic composition comprising (a) a lipid dendritic cell targeting moiety to which is covalently linked a metal chelating group; (b) an antigen comprising a metal affinity tag; and optionally (c) metal ions, whereby the antigen is linked to the lipid dendritic cell targeting moiety via the interaction between the metal affinity tag and the metal chelating group. | 09-25-2008 |
| 20100129385 | IMMUNOGENIC MOLECULES - The present invention relates generally to the field of immunology and more particularly to molecules capable of stimulating a cellular immune response. More particularly, the present invention provides self-adjuvanting immunogenic molecules capable of stimulating an immune response to epitopes of a polypeptide irrespective of a subjects HLA type. The present invention further contemplates methods for the production and use of the self-adjuvanting immunogenic molecules and compositions comprising same useful in the vaccination of subjects against specific polypeptides. | 05-27-2010 |
| 20110200632 | ADJUVANTING MATERIAL - The present invention provides an adjuvanting material, the adjuvanting material comprising a lipid dendritic cell targeting moiety to which is covalently linked a metal chelating group. Further, the present invention provides an immunogenic composition comprising (a) a lipid dendritic cell targeting moiety to which is covalently linked a metal chelating group; (b) an antigen comprising a metal affinity tag; and optionally (c) metal ions, whereby the antigen is linked to the lipid dendritic cell targeting moiety via the interaction between the metal affinity tag and the metal chelating group. | 08-18-2011 |
David Charles Jackson, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20100143405 | Immunotherapy of virus infection - The present invention relates to a method of treating or preventing a virus infection in a subject. In particular, it relates to the use of autologous dendritic cells that have been matured and loaded ex vivo with hepatitis C virus (HCV) antigens, to initiate a cellular immune response in HCV-positive patients, after autologous transfusion. | 06-10-2010 |
David Charles Jackson, North Balwyn Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20100266623 | SYNTHETIC, SELF ADJUVANTING VACCINES - The present invention relates generally to the field of immunotherapy, and more particularly to immunomedicaments in the form of lipopeptides which induce an antibody response to drugs of dependence, and uses thereof in the treatment and prevention of drug addiction. | 10-21-2010 |
David Charles Jackson, North Balwyn AU
| Patent application number | Description | Published |
|---|---|---|
| 20090105155 | TRUNCATED LHRH FORMULATIONS - The present invention provides a peptide useful for raising an antiLHRH response in an animal. The peptide comprises a first and second region, the first region consisting of a sequence of less than 60 amino acids which comprises at least one T helper cell epitope and the second region consisting of the sequence SYGLRPG. | 04-23-2009 |
| 20100310595 | METHOD OF TRANSFECTION AND COMPOSITIONS THEREFOR - The present invention relates to the targeted delivery of molecules to cells expressing toll-like receptors (TLRs). Aspects of the invention provide compounds comprising a positively charged group linked to a TLR ligand. These compounds are useful for in vitro and in vivo methods of transfection of TLR-expressing cells. Other aspects of the invention relate to the use of such compounds for repression of gene expression and DNA vaccination approaches. | 12-09-2010 |
| 20110262473 | SYNTHETIC VACCINE COMPONENT - The present invention relates generally to the field of synthetic vaccines, components thereof and methods for producing same. More particularly, the present invention provides a component of synthetic vaccines and its use in a modular approach to vaccine production. | 10-27-2011 |
Garrry Raymond Jackson, Balmain AU
| Patent application number | Description | Published |
|---|---|---|
| 20110310186 | PRINTHEAD SUPPORT STRUCTURE WITH CAVITIES FOR PULSE DAMPING - A structure for an inkjet printhead is disclosed. The printhead structure has an elongate support structure for supporting a printhead integrated circuit, and ink conduits formed in the elongate support structure for supplying ink to an array of nozzles of the printhead integrated circuit. Each ink conduit includes cavities distributed along a roof of the ink conduit. An opening to each cavity has an upstream edge and a downstream edge. The upstream edge contacts the ink before the downstream edge during initial priming of the ink conduits from an ink supply. The upstream edge has a transition face between the ink conduit and the cavity interior, the transition face being configured to inhibit ink from filling the cavity by capillary action during initial priming of the ink conduit. This causes gas to be trapped within the cavity. The gas acts to compress pressure pulses in the ink. | 12-22-2011 |
Gary Raymond Jackson, Balmain AU
| Patent application number | Description | Published |
|---|---|---|
| 20080230468 | HIGH FLOWRATE FILTER FOR INKJET PRINTHEAD - A filter for an inkjet printer that has a chamber divided into an upstream section and a downstream section by a filter membrane. An inlet conduit establishes fluid communication between an ink supply and the upstream section. An outlet conduit establishes fluid communication between the downstream section and a printhead. During use at least part of the inlet conduit is elevated relative to the filter membrane. By elevating the inlet conduit relative to the filter membrane, it acts as a bubble trap to retain bubbles that would otherwise obstruct the filter. This allows the filter size to be reduced for a more compact overall design. | 09-25-2008 |
| 20080303881 | INK SUPPLY ARRANGEMENT FOR INKJET PRINTHEAD HAVING LARGE NOZZLE NUMBER - An ink supply arrangement for an inkjet printhead is provided having at least one collapsible ink bag containing ink for distribution to nozzles of the printhead via a fluid path between the ink bag and nozzles, a body for housing the ink bag and the printhead, and a biasing member in the ink bag. The ink is primed in the fluid path and nozzles so as to be ejected by the nozzles, in use, thereby depleting the ink contained in the ink bag. The ink bag is attached to the body at a wall opposite a wall of the ink bag facing the printhead. The biasing member applies outwardly directed force on the wall of the ink bag facing the printhead thereby maintaining substantially constant negative pressure at the nozzles as the ink is depleted. The fluid path connects the ink bag to at least 6400 nozzles of the printhead. | 12-11-2008 |
Graeme D. Jackson, Victoria AU
James E. Jackson, Wamboin AU
| Patent application number | Description | Published |
|---|---|---|
| 20100005122 | DYNAMIC INFORMATION SYSTEMS - This invention discloses the concept of a dynamic metasystem managing a dynamic system, achieved through the use of, and an environment (i.e., tools and ontologies) supporting dynamic artifacts. A system for generating a dynamic information system comprises a persistent dynamic repository of data and an integration metasystem. The repository forms an asymmetric navigational database, and the database includes an ontology model. The ontology model has an abstract model framework that supports creation and use of multi-dimensional and asymmetric abstract models of data, and views which define the content and form of presentation of that data using a computer. The integration metasystem includes components that describe components of shared infrastructure and services of an enterprise architecture, and a dynamic information system software tool generating artifacts representing information and views that define the presentation of data. The artifacts are provided to the ontology model, and have interfaces to the abstract model framework that permit creation, reading and modification of the contents of the asymmetric navigational database. | 01-07-2010 |
| 20100332542 | METHOD, SYSTEM, AND PROGRAM PRODUCT FOR DISCOVERING RELEVANT INFORMATION IN A DYNAMIC INFORMATION SYSTEM - The invention provides a method, system, and program product for discovering relevant information in a dynamic information system (DIS). An illustrative method according to the invention includes comparing information provided by the user to information in a network, determining whether the network contains information relevant to the information provided by the user, and displaying to the user an object containing the relevant information. | 12-30-2010 |
Jeffrey Allan Jackson, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20090068866 | Elongate Electrical Conductor That is Adapted for Electrically Connecting With an Electrical Contact - An elongate electrical conductor ( | 03-12-2009 |
Mark Jackson, Queensland AU
| Patent application number | Description | Published |
|---|---|---|
| 20090070895 | VACUOLE TARGETING PEPTIDE AND NUCLEIC ACID - The present invention relates to a plant vacuole targeting sequence X | 03-12-2009 |
Robert Jackson, Lane Cove AU
| Patent application number | Description | Published |
|---|---|---|
| 20100173690 | CARD SELECTION GAME WITH FEATURE - A gaming machine and method are disclosed. A selected symbol is displayed in a non-revealed manner, for example on a display, a player having nominated at least one characteristic of the symbol. If the selected symbol is revealed to have the nominated characteristic a prize is awarded to the player, and if the symbol is revealed to be a special symbol a game controller awards the player a feature outcome that comprises a plurality of bonus plays of a feature game that includes at least one special symbol. Progression to the next bonus play in the plurality of bonus plays is dependent on selection of the special symbol. | 07-08-2010 |
Robert James Jackson, Rosebery AU
| Patent application number | Description | Published |
|---|---|---|
| 20110183755 | GAMING SYSTEM AND A METHOD OF GAMING - A gaming system comprising a display, an object selector arranged to select at least one object to be placed in each container of a set of a plurality of containers displayed on the display and an outcome generator arranged to determine a game outcome based on at least one characteristic of the object or objects placed in at least part of each container of the set of containers. | 07-28-2011 |
Robert James Jackson, Earlwood AU
| Patent application number | Description | Published |
|---|---|---|
| 20080227519 | GAMING SYSTEM AND A METHOD OF GAMING - A gaming system comprising a display, an object selector arranged to select at least one object to be placed in each container of a set of a plurality of containers displayed on the display and an outcome generator arranged to determine a game outcome based on at least one characteristic of the object or objects placed in at least part of each container of the set of containers. | 09-18-2008 |
Roy William Jackson, Camberwell AU
| Patent application number | Description | Published |
|---|---|---|
| 20090143565 | Methods for the Synthesis of Two or More Dicarba Bridges in Organic Compounds - Described herein are methods for forming two or more dicarba bridges, as well as new compounds containing dicarba bridges. | 06-04-2009 |
Shaun Jackson, Melbourne AU
| Patent application number | Description | Published |
|---|---|---|
| 20080206312 | Therapeutic Morpholino-Substituted Compounds - Morpholino-substituted pyridopyrimidine, quinolone, and benzopyranone derivatives inhibit phosphoinositide (PI) 3-kinase, an enzyme that regulates platelet-adhesion processes. As a consequence, the compounds in question have anti-thrombotic activity, as well as other pharmaceutical properties. The compounds claimed are represented by formula (I), (II) and (III). PI 3-kinase generates 3-phosphorylated PI second messengers which stimulate platelet adhesion under blood-flow conditions. Because platelet adhesion is a necessary step in the formation of a thrombus, inhibition by these compounds of PI 3-kinase under such conditions inhibits or prevents thrombus formation. The compounds are useful in treating PI 3-kinase-dependent conditions including cardiovascular diseases such as coronary artery occlusion, stroke, acute coronary syndrome, acute myocardial infarction, vascular restenosis, atherosclerosis, and unstable angina; respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), and bronchitis; inflammatory disorders; neoplasms including cancers such as glioma, prostate cancer, small cell lung cancer, and breast cancer; and diseases linked to disordered white blood cell function, such as autoimmune and inflammatory diseases. | 08-28-2008 |
| 20080312233 | Therapeutic Morpholino-Substituted Compounds - Morpholino-substituted pyridopyrimidine, quinolone, and benzopyranone derivatives inhibit phosphoinositide (PI) 3-kinase, an enzyme that regulates platelet-adhesion processes. As a consequence, the compounds in question have anti-thrombotic activity, as well as other pharmaceutical properties. The compounds claimed are represented by formula (I), (II) and (III). PI 3-kinase generates 3-phosphorylated PI second messengers which stimulate platelet adhesion under blood-flow conditions. Because platelet adhesion is a necessary step in the formation of a thrombus, inhibition by these compounds of PI 3-kinase under such conditions inhibits or prevents thrombus formation. The compounds are useful in treating PI 3-kinase-dependent conditions including cardiovascular diseases such as coronary artery occlusion, stroke, acute coronary syndrome, acute myocardial infarction, vascular restenosis, atherosclerosis, and unstable angina; respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), and bronchitis; inflammatory disorders; neoplasms including cancers such as glioma, prostate cancer, small cell lung cancer, and breast cancer; and diseases linked to disordered white blood cell function, such as autoimmune and inflammatory diseases. | 12-18-2008 |
Shaun Jackson, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20090191177 | Enantiomerically Pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-A]pyrimidin-9-yl)et- hylamino]benzoic Acid, Its Use In Medical Therapy, And A Pharmaceutical Composition Comprising It - 026 - The present invention relates to enantiomerically pure (−) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid or pharmaceutically acceptable salts thereof, it being in a solid state, its use in medical therapy, pharmaceutical composition comprising it, its use in the preparation of a medicament for use in a method for preventing or treating diseases, and its use in method for preventing or treating disease. The present invention relates to a selective inhibitor of phosphoinositide (PI) 3-kinase β and use of the selective inhibitor in e.g. anti-thrombotic therapy. | 07-30-2009 |
| 20110190270 | METHODS OF TREATING THROMBOEMBOLIC DISORDERS - The field of the invention relates to methods for dissolving a thrombus using inhibitors of platelet contractility. More particularly, the present invention relates to the use of an inhibitor of platelet contractility in combination with one or more thrombolytic agents and optionally one or more anticoagulants for inhibiting platelet contraction and consolidation in the developing thrombus. | 08-04-2011 |
Shaun P. Jackson, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20080319021 | Inhibition Of Phosphoinositide 3-Kinase Beta - The present invention relates to selective inhibitors of phosphoinositide (PI) 3-kinase β, use of the selective inhibitors in anti-thrombotic therapy, and a method for screening compounds useful for the new anti-thrombotic therapy by detecting selective inhibitory activity of PI 3-kinase β of the compound. The invention also relates to novel compounds that are inhibitors of PI 3-kinase. | 12-25-2008 |
Shaun Phillip Jackson, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20120058500 | PLATELET AGGREGATION USING A MICROFLUIDICS DEVICE - A microfluidics device to provide real time monitoring of platelet aggregation of a biological sample obtained from a subject. The device comprises a channel configured for passage of the biological sample, the channel comprising a protrusion configured to induce an upstream region of shear acceleration coupled to a downstream region of shear deceleration and defining there-between a region of peak rate of shear, the downstream region of shear deceleration defining a zone of platelet aggregation. The device further comprises a platelet detection means for detecting aggregation of platelets in the zone of aggregation as a result of passage of the biological sample through the channel. Methods to assess real time platelet aggregation of a biological sample obtained from a subject are further described. | 03-08-2012 |
Stuart Jackson, Hillsdale AU
| Patent application number | Description | Published |
|---|---|---|
| 20090136444 | MOLECULE AND CHIMERIC MOLECULES THEREOF - The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule in or related to the IL-6 protein family such as G-CSF, IL-11, IL-6, LIF or chimeric molecules thereof, comprising at least a portion of the protein molecule; wherein the protein or chimeric molecule thereof has a profile of measurable physiochemical parameters, wherein the profile is indicative of, associated with or forms the basis of one or more pharmacological traits. The present invention further contemplates the use of the isolated protein or chimeric molecule thereof in a range of diagnostic, prophylactic, therapeutic, nutritional and/or research applications. | 05-28-2009 |
Stuart Jackson, New South Wales AU
| Patent application number | Description | Published |
|---|---|---|
| 20090175819 | MOLECULE AND CHIMERIC MOLECULES THEREOF - The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule that comprises a dimeric 4-helix bundle, such as IFN-a2B, IFN-b1, IFN-g, IL-10 or its receptor, such as IFNAR2, IL-10Ra or chimeric molecules thereof comprising at least a portion of the protein molecule, such as IFN-a2B-Fc, IFN-b1-Fc, IFN-g-Fc, IFNAR2-Fc, IL-IO-Fc, IL-10Ra-Fc; wherein the protein or chimeric molecule thereof has a profile of measurable physiochemical parameters, wherein the profile is indicative of, associated with or forms the basis of one or more pharmacological traits. The present invention further contemplates the use of the isolated protein or chimeric molecule thereof in a range of diagnostic, prophylactic, therapeutic, nutritional and/or research applications. | 07-09-2009 |
Wayne Keven Jackson, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20100060989 | SECURITY DOCUMENT WITH MICRO-PRISMS - A security document including a substrate of transparent polymeric material, and opacifying layers provided on opposing sides of the substrate, the opacifying layers acting to guide light propagating within the substrate, wherein the substrate is formed with at least one micro-prism for diverting light propagating within or entering the substrate. | 03-11-2010 |
Wayne Kevin Jackson, Rosanna AU
| Patent application number | Description | Published |
|---|---|---|
| 20100084850 | SECURITY DOCUMENT CONTAINING AN AUTHENTICATION DEVICE - A flexible security document is provided which contains an authentication device including: a) source of electrical potential ( | 04-08-2010 |
William Roy Jackson, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20090186976 | Crosslinking Method - The invention provides a method of preparing a crosslinked polymer, which method comprises polymerising branched polyunsaturated monomers by a metathesis polymerisation reaction, wherein the branched polyunsaturated monomers contain acyclic ethylenically unsaturated groups that are capable of undergoing polymerization by a metathesis reaction such that the metathesis polymerisation produces a crosslinked polymer and substantially no non-volatile ethylenically unsaturated by-products. | 07-23-2009 |
William Roy Jackson, Camberwell AU
| Patent application number | Description | Published |
|---|---|---|
| 20100036089 | Methods for the Synthesis of Dicarba Bridges in Organic Compounds - The present invention relates to methods for forming dicarba bridges in organic compounds. This involves the use of a pair of complementary metathesisable groups on the organic compound, and subjecting the compound to cross-metathesis under microwave radiation conditions. In an alternative, the compounds contain a turn-inducing group between the pair of cross-metathesisable groups to facilitate the cross-metathesis. | 02-11-2010 |